The inflammatory pathogenic role of IL-6 is recognized in many autoimmune diseases, including rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), and thus IL-6 signaling is targeted therapeutically in many of them (3, 48, 49). This evidence concerns the gene IL6 and rheumatoid arthritis.